Physician profile
Marc Cillo
NPI 1750726287
$277.66
in general payments reported to CMS, 2019-2025
7 companies · $16.27 in 2025
The $16.27 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $33.09 · 2020: $14.55 · 2021: $34.29 · 2023: $35.53 · 2024: $144 · 2025: $16.27.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $196.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $195.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Beta Bionics, INC. | $143.93 | 2024 | Ilet Bionic Pancreas |
| Dexcom, INC. | $48.84 | 2020-2021 | |
| Intuity Medical INC | $20.19 | 2023 | Pogo Automatic Blood Glucose Monitoring System |
| Shire North American Group INC | $19.24 | 2019 | |
| Boston Scientific Corporation | $16.27 | 2025 | Watchman Flx |
| Tandem Diabetes Care, INC. | $15.34 | 2023 | T:Slim X2 Insulin Pump With Control-Iq |
| Janssen Pharmaceuticals, INC | $13.85 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marc Cillo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.